The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Cancer stem cells: The root of tumor recurrence and metastases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–242 of 242
Martin, P., Liu, Y., Pierce, R. M., Abou-Kheir, W. G., Casey, O. M., Seng, V., Camacho, D. F., Simpson, R. J., & Kelly, K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.035 · Cited by 100
Chromatin and oxygen sensing in the context of JmjC histone demethylases
Shmakova, A., Batie, M., Druker, J., & Rocha, S. (2014) · Biochemical Journal · doi:10.1042/bj20140754 · Cited by 99
Intra‐tumour heterogeneity – going beyond genetics
Caiado, F., Silva‐Santos, B., & Norell, H. (2016) · FEBS Journal · doi:10.1111/febs.13705 · Cited by 96
Choi, E., Nam, J., Jung, J., Cho, N., & Cho, S. (2014) · Scientific Reports · doi:10.1038/srep07162 · Cited by 95
Oncogenes create a unique landscape of fragile sites
Miron, K., Golan‐Lev, T., Dvir-Szternfeld, R., Ben‐David, E., & Kerem, B. (2015) · Nature Communications · doi:10.1038/ncomms8094 · Cited by 94
Reuben, J. M., Lee, B.-N., Gao, H., Cohen, E. N., Mego, M., Giordano, A., Wang, X., Lodhi, A., Krishnamurthy, S., Hortobágyi, G. N., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.011 · Cited by 93
Civenni, G., Malek, A. V., Albino, D., García‐Escudero, R., Napoli, S., Marco, S. D., Pinton, S., Sarti, M., Carbone, G. M., & Catapano, C. V. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0615 · Cited by 92
Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ
Escoll, M., Gargini, R., Cuadrado, A., Antón, I. M., & Wandosell, F. G. (2017) · Oncogene · doi:10.1038/onc.2016.518 · Cited by 92
Gyanchandani, R., Lin, Y., Lin, H., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2889 · Cited by 88
An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells
Peitzsch, C., Cojoc, M., Hein, L., Kurth, I., Mäbert, K., Trautmann, F., Klink, B., Schröck, E., Wirth, M. P., Krause, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2116 · Cited by 87
Self-citationCancer stem cells as ‘units of selection’
Greaves, M. F. (2012) · Evolutionary Applications · doi:10.1111/eva.12017 · Cited by 86
Metformin and prostate cancer stem cells: a novel therapeutic target
Mayer, M., Klotz, L. H., & Venkateswaran, V. K. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.35 · Cited by 85
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis
Nguyen, A., Loo, J. M., Mital, R., Weinberg, E. M., Man, F. Y., Zeng, Z., Paty, P. B., Saltz, L. B., Janjigian, Y. Y., de Stanchina, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83587 · Cited by 85
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
Gazzaniga, P., Gradilone, A., Petracca, A., Nicolazzo, C., Raimondi, C., Iacovelli, R., Naso, G., & Cortesi, E. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01117.x · Cited by 84
Hulin, C., Belch, A. R., Shustik, C., Petrucci, M. T., Dührsen, U., Lu, J., Song, K., Rodon, P., Pegourié, B., Garderet, L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7295 · Cited by 83
Larzábal, L., El-Nikhely, N. A., Redrado, M., Seeger, W., Savai, R., & Calvo, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079798 · Cited by 81
Tjhay, F., Motohara, T., Tayama, S., Narantuya, D., Fujimoto, K., Guo, J., Sakaguchi, I., Honda, R., Tashiro, H., & Katabuchi, H. (2015) · Cancer Science · doi:10.1111/cas.12765 · Cited by 80
Bartkowiak, K., Kwiatkowski, M., Buck, F., Gorges, T. M., Nilse, L., Assmann, V., Andreas, A., Müller, V., Wikman, H., Riethdorf, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3728 · Cited by 79
Self-citationHigh-throughput screening of small molecules identifies hepcidin antagonists
Fung, E., Sugianto, P., Hsu, J., Damoiseaux, R., Ganz, T., & Nemeth, E. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.083428 · Cited by 78
Reid, A. L., Millward, M., Pearce, R., Lee, M., Frank, M. H., Ireland, A., Monshizadeh, L., Rai, T., Heenan, P. J., Medic, S., et al. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12057 · Cited by 78
Piha-Paul, S. A., Münster, P. N., Hollebecque, A., Argilés, G., Dajani, O. F., Cheng, J., Wang, R., Swift, A., Tosolini, A., & Gupta, S. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.115 · Cited by 77
Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells
Lin, R.-K., Hsu, C., & Wang, Y. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282a215e9 · Cited by 69
EMT-induced metabolite signature identifies poor clinical outcome
Bhowmik, S. K., Ramirez‐Peña, E., Arnold, J. M., Putluri, V., Sphyris, N., Michailidis, G. C., Putluri, N., Ambs, S., Sreekumar, A., & Mani, S. A. (2015) · Oncotarget · doi:10.18632/oncotarget.4765 · Cited by 66
An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
Zhang, H., Liu, L., Yu, D., Kandimalla, E. R., Sun, H. B., Agrawal, S., & Guha, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038111 · Cited by 66
Barbieri, F., Thellung, S., Ratto, A., Carra, E., Marini, V., Fucile, C., Bajetto, A., Pattarozzi, A., Würth, R., Gatti, M., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1235-8 · Cited by 61
Katoh, S., Goi, T., Naruse, T., Ueda, Y., Kurebayashi, H., Nakazawa, T., Kimura, Y., Hirono, Y., & Yamaguchi, A. (2015) · PubMed · Cited by 60
Zhao, L., Zhao, Y., Schwarz, B., Mysliwietz, J., Hartig, R., Čamaj, P., Bao, Q., Jauch, K., Guba, M., Ellwart, J. W., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3512 · Cited by 59
Knowles, S. M., Zettlitz, K. A., Tavaré, R., Rochefort, M. M., Salazar, F. B., Stout, D. B., Yazaki, P. J., Reiter, R. E., & Wu, A. M. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120873 · Cited by 58
Perivascular stem cell niche in head and neck cancer
Ritchie, K., & Nor, J. E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.025 · Cited by 55
Metformin and Cancer Stem Cells: Old Drug, New Targets
Bednar, F., & Simeone, D. M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0026 · Cited by 51
Saha, S., Mukherjee, S., Mazumdar, M., Manna, A., Khan, P., Adhikary, A., Kajal, K., Jana, D., Sa, G., Mukherjee, S., et al. (2014) · Translational research · doi:10.1016/j.trsl.2014.10.011 · Cited by 50
Helou, R. E., Wicinski, J., Guillé, A., Adélaı̈de, J., Finetti, P., Bertucci, F., Chaffanet, M., Birnbaum, D., Charafe‐Jauffret, E., & Ginestier, C. (2014) · Stem Cells · doi:10.1002/stem.1792 · Cited by 49
Cattoglio, C., Zhang, E., Grubisic, I., Chiba, K., Fong, Y. W., & Tjian, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505569112 · Cited by 46
Werner, S., Brors, B., Eick, J., Marques, E., Pogenberg, V., Parret, A. H. A., Kemming, D., Wood, A. W., Edgren, H., Neubauer, H. J., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1042 · Cited by 46
Self-citationHypoxic conditions differentially regulate TAZ and YAP in cancer cells
Yan, L., Cai, Q., & Xu, Y. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.024 · Cited by 43
Metabolic plasticity of cancer stem cells
Luo, M., & Wicha, M. S. (2015) · Oncotarget · doi:10.18632/oncotarget.6177 · Cited by 38
Knowles, S. M., Tavaré, R., Zettlitz, K. A., Rochefort, M. M., Salazar, F. B., Jiang, Z. K., Reiter, R. E., & Wu, A. M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1452 · Cited by 33
Gelao, L., Criscitiello, C., Fumagalli, L. A. M., Locatelli, M., Manunta, S., Esposito, A., Minchella, I., Goldhirsch, A., & Curigliano, G. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2013.320 · Cited by 32
Association of stem cell marker CD133 expression with dissemination of glioblastomas
for the Tohoku Brain Tumor Study Group, Satō, A., Sakurada, K., Kumabe, T., Sasajima, T., Beppu, T., Asano, K., Ohkuma, H., Ogawa, A., Mizoi, K., et al. (2010) · Neurosurgical Review · doi:10.1007/s10143-010-0239-8 · Cited by 32
Deciphering intratumor heterogeneity using cancer genome analysis
Ryu, D., Joung, J., Kim, N. K. D., Kim, K., & Park, W. (2016) · Human Genetics · doi:10.1007/s00439-016-1670-x · Cited by 28
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar
Fracasso, P. M., Blum, K. A., Ma, M. K., Tan, B. R., Wright, L. P., Goodner, S. A., Fears, C. L., Hou, W., Arquette, M. A., Picus, J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602653 · Cited by 27
Reparixin, a Specific Interleukin-8 Inhibitor, Has No Effects on Inflammation during Endotoxemia
Leitner, J. M., Mayr, F., Firbas, C., Spiel, A. O., Steinlechner, B., Novellini, R., & Jilma, B. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000104 · Cited by 21
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273
Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism
Ke, R., Xu, Q., Li, C., Luo, L., & Huang, D. (2018) · Cell Biology International · doi:10.1002/cbin.10915 · Cited by 414
Chemotherapy: a double-edged sword in cancer treatment
Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2022) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-021-03013-3 · Cited by 397
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
Begicevic, R.-R., & Falasca, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112362 · Cited by 395
Metadata
- Authors
- Peitzsch, C., Tyutyunnykova, A., Pantel, K., & Dubrovska, A.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 44
- Pages
- 10-24
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2592828140
- Cited by
- 372
- References
- 242
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.